TCPG
BSX icon

Trivant Custom Portfolio Group’s Boston Scientific BSX Stock Holding History

Trivant Custom Portfolio Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,370
Closed -$713K – 83
2026
Q1 		$713K Buy
11,370
+1,651
+17% +$132K 0.39% 66
2025
Q4 		$927K Buy
+9,719
New +$953K 0.53% 53

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Trivant Custom Portfolio Group's BSX Position: Q2 2026 in Review

Trivant Custom Portfolio Group sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 11,370 shares — an estimated $713K sold.

Trivant Custom Portfolio Group first reported a position in BSX in Q4 2025 and held it in 2 quarters. The position peaked at $927K in Q4 2025. 1,478 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Trivant Custom Portfolio Group reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Trivant Custom Portfolio Group sold 11,370 Boston Scientific shares in Q2 2026, an estimated $713K.
  • Trivant Custom Portfolio Group first reported a position in Boston Scientific in Q4 2025 and held it in 2 quarters.
  • Trivant Custom Portfolio Group's Boston Scientific position peaked at $927K in Q4 2025.
  • 1,478 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Trivant Custom Portfolio Group's 13F filing for Q2 2026, filed 27 Jul 2026.